Search
Filter by Topic
- People (106) Apply People filter
- Reproduction (102) Apply Reproduction filter
- Publications (100) Apply Publications filter
- Experiments (91) Apply Experiments filter
- Technologies (58) Apply Technologies filter
- Legal (49) Apply Legal filter
- Disorders (48) Apply Disorders filter
- Processes (33) Apply Processes filter
- Theories (26) Apply Theories filter
- Ethics (22) Apply Ethics filter
- Organizations (20) Apply Organizations filter
- Outreach (19) Apply Outreach filter
- Organisms (8) Apply Organisms filter
- Religion (4) Apply Religion filter
- Reproductive Health Arizona (3) Apply Reproductive Health Arizona filter
- DNA (1) Apply DNA filter
- Publication (1) Apply Publication filter
- RHAZ (1) Apply RHAZ filter
Studies of Thalidomide's Effects on Rodent Embryos from 1962-2008
Thalidomide is a sedative drug introduced to European markets on 1 October 1957 after extensive testing on rodent embryos to ensure its safety. Early laboratory tests in rodent populations showed that pregnant rodents could safely use it, so doctors prescribed Thalidomide to treat morning sickness in pregnant women. However, in humans Thalidomide interfered with embryonic and fetal development in ways not observed in rodent tests.
Format: Articles
Subject: Organisms, Reproduction, Disorders
Rh Incompatibility in Pregnancy
Rh factor is a protein found on the outside of Rh-positive red blood cells. Rh incompatibility during pregnancy occurs when an Rh-negative mother is pregnant with an Rh-positive fetus. During delivery, the fetus' Rh-positive blood is introduced into the mother’s body. The Rh-negative mother’s body begins to produce antibodies that attack and kill Rh-positive blood cells. Since the crossover of blood normally occurs during delivery, an Rh-negative woman’s first pregnancy is normally not affected.
Format: Graphics
Subject: Processes
“What Can We Do About Cancer? The Most Vital and Insistent Question in the Medical World” (1913), by Samuel Hopkins Adams
In 1913, journalist Samuel Hopkins Adams published “What Can We Do About Cancer? The Most Vital and Insistent Question in the Medical World,” hereafter “What Can We Do About Cancer,” in Ladies’ Home Journal. Cancer is a disease that is the result of abnormal cell division in different parts of the body, such as the breasts or the cervix. During that time, many women did not discuss or disclose early symptoms of reproductive cancers, such as breast lumps and abnormal vaginal discharge, out of shame or disgust. Thus, people often considered cancer to be a taboo topic.
Subject: Publications
George Nicholas Papanicolaou (1883–1962)
George Nicholas Papanicolaou developed the Pap test in the United States during the twentieth century. The Pap test is a diagnostic procedure used to test for cervical cancer in women. Papanicolaou’s work helped improve the reproductive health of women by providing an effective means of identifying precancerous cells and improving the likelihood of early treatment and survival of cervical cancer.
Format: Articles
Subject: People, Reproduction
Diana W. Bianchi
Diana W. Bianchi studied the medical treatment of premature and newborn infants in the US during the twentieth and twenty-first centuries. Bianchi helped develop non-invasive prenatal genetic tests that use cell-free fetal DNA found within maternal blood to diagnose genetic abnormalities of the fetus during pregnancy. The test provides a means to test fetuses for chromosomal and genetic abnormalities.
Format: Articles
Subject: People
Chorionic Villus Sampling
Chorionic villus sampling (CVS) is a test used for prenatal diagnosis. Safe to perform at an earlier stage in pregnancy than amniocentesis, CVS is another invasive prenatal diagnostic test that can be performed as early as ten weeks after the woman's last menstrual cycle. While this test does carry some risks, it is generally very effective at predicting heritable diseases during or soon after the embryonic stage of development.
Format: Articles
Subject: Technologies
“HeLa Cells 50 Years On: The Good, The Bad, and The Ugly” (2002), by John R. Masters
Published in 2002, prostate cancer researcher John R. Masters authored a review article HeLa Cells 50 Years On: The Good, The Bad, and The Ugly that described the historical and contemporary context of the HeLa cell line in research in Nature Reviews Cancer. The HeLa cell line was one of the first documented immortal cell lines, isolated from cervical cancer patient Henrietta Lacks in 1951 at The Johns Hopkins Hospital in Baltimore, Maryland. An immortal cell line is a cluster of cells that continuously multiply on their own outside of the original host.
Format: Articles
Subject: Publications
“Transfer of a Human Zygote” (1973), by David De Kretzer, Peter Dennis, Bryan Hudson, John Leeton, Alexander Lopata, Ken Outch, James Talbot, and Carl Wood
On 29 September 1973, researchers David De Kretzer, Peter Dennis, Bryan Hudson, John Leeton, Alexander Lopata, Ken Outch, James Talbot, and Carl Wood published “Transfer of a Human Zygote,” in The Lancet. In the article, the authors describe an experiment that resulted in one of the first pregnancies established via in vitro fertilization, or IVF. Prior to the article’s publication in 1973, there was no published evidence demonstrating whether IVF treatment would work in humans, although evidence existed showing that IVF worked in other mammals for breeding purposes.
Format: Articles
Subject: Publications, Processes
Retinoids As Teratogens
Vitamin A (retinol) is an essential vitamin in the daily functioning of human beings that helps regulate cellular differentiation of epithelial tissue. Studies have shown that an excess of vitamin A can affect embryonic development and result in teratogenesis, or the production of birth defects in a developing embryo. Excess intake of vitamin A and retinoids by pregnant women often results malformations to fetuses' skulls, faces, limbs, eyes, central nervous system.
Format: Articles
Subject: Disorders, Reproduction
Edwin Carlyle (Carl) Wood (1929–2011)
Edwin Carlyle Wood, also known as Carl Wood, was a physician who helped develop in vitro fertilization, or IVF, treatments. From 1964 to 1992, Wood worked as a professor of obstetrics and gynecology at Monash University in Melbourne, Australia, where he was one of the first in the world to lead a team of physicians to establish IVF as a proven treatment for infertility. IVF refers to a medical procedure in which scientists inseminate an egg cell with a sperm cell outside of the body, such as in a glass dish in a clinical setting.
Format: Articles
Subject: People, Technologies, Reproduction
Thesis: How Purported Scientific Failures Have Led to Advancements in IVF
This thesis shows us the history of how some of the first attempts at IVF in humans using various options such as donated egg cells and cryopreserved embryos, often ended in early miscarriages. At that time, most members of the scientific community and general public responded to those trials by regarding them as insignificant. In 1998, the success rate of women under the age of 38 having children with the use of IVF was 22.1%. Over time, scientists began to acknowledge those published findings that detailed various “failed” human IVF experiments.
Format: Essays and Theses
Subject: Publications, Technologies, Experiments, Reproduction, Outreach
History of the Monash IVF Research Program from 1971 to 1989
In 1971, a group of researchers founded the Monash IVF Research Program with the mission to discover how in vitro fertilization, or IVF, techniques could become a treatment for infertility in both men and women. The program included researcher Carl Wood and colleagues John Leeton, Alex Lopata, Alan Trounson, and Ian Johnston at the Queen Victoria Medical Center and Royal Women’s Hospital in Melbourne, Australia. Since the program’s establishment in 1971, the Monash IVF Research Program has helped to develop and implement many IVF technologies still used in clinical practice as of 2020.
Format: Articles
Subject: Organizations, Reproduction
Gestational Diabetes
Gestational diabetes is a medical condition that causes blood sugar levels to become abnormally high, which manifests for the first-time during pregnancy and typically disappears immediately after birth for around ninety percent of affected women. While many women with the condition do not experience any noticeable symptoms, some may experience increased thirst and urination.
Format: Articles
Subject: Reproduction, Disorders
US Regulatory Response to Thalidomide (1950-2000)
Thalidomide, a drug capable of causing fetal abnormalities (teratogen), has caused greater than ten thousand birth defects worldwide since its introduction to the market as a pharmaceutical agent. Prior to discovering thalidomide's teratogenic effects in the early 1960s, the US Food and Drug Administration (FDA) did not place regulations on drug approval or monitoring as it later did. By 1962, approximately 20,000 patients in the US had taken thalidomide as part of an unregulated clinical trial before any actions were taken to stop thalidomide's distribution.
Format: Articles
Subject: Legal, Reproduction
"Presence of Fetal DNA in Maternal Plasma and Serum" (1997), by Dennis Lo, et al.
In the late 1990s researchers Yuk Ming Dennis Lo and his colleagues isolated fetal DNA extracted from pregnant woman’s blood. The technique enabled for more efficient and less invasive diagnoses of genetic abnormalities in fetuses, such as having too many copies of chromosomes.
Format: Articles
Subject: Experiments
Menstrual Tampon
Menstrual tampons are feminine hygiene devices, usually made of absorbent cotton, that are temporarily inserted into the vagina for absorbing a woman’s blood during menstruation. In 1931, Earl Haas invented the menstrual tampon most commonly used in the twenty-first century. Later, Gertrude Tendrich produced the first commercial tampon brand, Tampax, using Haas’s patented design. Tendrich and Haas’s tampon was made of tightly compacted absorbent cotton, shaped like a bullet, and had a string attached at the base that allowed for easy removal from the woman’s body.
Format: Articles
Subject: Technologies
Ferguson v. City of Charleston (2001)
The US Supreme Court case Ferguson v. City of Charleston (2001) established that public hospitals couldn't legally drug test pregnant women without their consent when those women sought prenatal care at those hospitals. The court held that such searches violated the pregnant women's protections under the Fourth Amendment to the US Constitution. The decisions also indicated those circumstances that qualified as special needs exceptions to the Fourth Amendment, and it highlighted the extent to which pregnant women are sovereign individuals in the eyes of the Court. Ferguson v.
Format: Articles
Subject: Legal
MicroSort
"MicroSort, developed in 1990 by the Genetics and IVF Institute, is a form of pre-conception sex selection technology for humans. Laboratories located around the world use MicroSort technology to help couples increase their chances of conceiving a child of their desired sex. MicroSort separates male sperm cells based on which sex chromosome they contain, which results in separated semen samples that contain a higher percentage of sperm cells that carry the same sex chromosome.
Format: Articles
Subject: Technologies
Transvaginal Ultrasound-Guided Oocyte Retrieval
Transvaginal ultrasound-guided oocyte retrieval, also known as egg retrieval, is a surgical technique used by medical professionals to extract mature eggs directly from the women’s ovaries under the guidance of ultrasound imaging. In 1982, physicians Suzan Lenz and Jorgen Lauritsen at the University of Copenhagen in Copenhagen, Denmark, proposed the technology to improve the egg collection aspect of in vitro fertilization, or IVF. During IVF, a healthcare practitioner must remove mature eggs from a woman’s ovaries to fertilize them with sperm outside of the body.
Format: Articles
Subject: Technologies, Reproduction
Henry Herbert Goddard (1866–1957)
Henry Herbert Goddard was a psychologist who conducted research on intelligence and mental deficiency at the Vineland Training School for Feeble-Minded Boys and Girls in Vineland, New Jersey during the early twentieth century. In 1908, Goddard brought French psychologist Alfred Binet and physician Theodore Simon’s intelligence test to the US and used it to investigate intellectual disability in children at the Vineland Training School for Feeble-Minded Boys and Girls.
Subject: People
Stafford Leak Warren (1896–1981)
Stafford Leak Warren studied nuclear medicine in the United States during the twentieth century. He used radiation to make images of the body for diagnosis or treatment and developed the mammogram, a breast imaging technique that uses low-energy X-rays to produce an image of breasts. Mammograms allow doctors to diagnose breast cancer in its early and most treatable stages.
Format: Articles
Subject: People
Amniocentesis
Amniocentesis is a test used for prenatal diagnosis of inherited diseases, Rh incompatibility, neural tube defects, and lung maturity. Normally performed during the second trimester of a pregnancy, this invasive procedure allows the detection of health problems in the fetus as early as fifteen weeks gestation. Although amniocentesis does carry some significant risks, the medical community commonly accepts it as a safe and useful procedure.
Format: Articles
Subject: Technologies, Reproduction
Thesis: A History and Analysis of Drug Labeling Policy for Pregnant and Lactating Women and Women's Involvement in Clinical Drug Research from 1970 to 2014
The problem of whether women should be involved in drug research is a question of who can assume risk and who is responsible for disseminating what specific kinds of information. The problem tends to be framed as one that juxtaposes the health of women and fetuses and sets their health as in opposition. That opposition, coupled with the inherent uncertainty in testing drugs, provides for a complex set of issues surrounding consent and access to information.
Format: Essays and Theses
Subject: Ethics
Doolan v. IVF America [Brief] (2000)
The implication of the court's decision was that Thomas Doolan's identity or personhood existed at the embryo stage in vitro, thus the fact that he was born with cystic fibrosis was not attributable to the decision of the in vitro fertilization providers to implant one embryo instead of another. The other unused embryo may not have carried the cystic fibrosis genes, but that other embryo was not Thomas Doolan. The decision in Doolan has not been publicly tested in other jurisdictions.
Format: Articles
Subject: Legal, Reproduction